Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 4, pp. 841-848
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 19, 2010
- Revision received October 4, 2010
- Accepted October 6, 2010
- Published first December 21, 2010.
Article Versions
- Previous version (December 21, 2010 - 07:42).
- Previous version (February 1, 2011 - 09:31).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- I. Jolanda M. de Vries1,2,
- Chiara Castelli4,
- Caroline Huygens5,
- Joannes F.M. Jacobs1,3,
- Julie Stockis5,
- Beatrice Schuler-Thurner6,
- Gosse J. Adema2,
- Cornelis J.A. Punt1,
- Licia Rivoltini4,
- Gerold Schuler6,
- Pierre G. Coulie5, and
- Sophie Lucas5
- Authors' Affiliations: Departments of 1Medical Oncology, 2Tumor Immunology, and 3Laboratory Medical Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, The Netherlands; 4Unit of Immunotherapy of Human Tumors, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy; 5de Duve Institute, Université catholique de Louvain, Brussels, Belgium; 6Hautklinik, Universitaetsklinikum Erlangen, Germany
- Corresponding Author:
Sophie Lucas, de Duve Institute, Université catholique de Louvain, avenue Hippocrate 75, B-1200, Brussels, Belgium. Phone: +32 2 764 7474; Fax: +32 2 764 7590; E-mail: Sophie.Lucas{at}uclouvain.be.
February 2011
Volume 17, Issue 4
Volume 17, Issue 4
Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
Jump to section
Advertisement